下一代结核病疫苗:进展,挑战和前景
Li Zhuang1,2, Zhaoyang Ye2, Linsheng Li2
1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, Eighth Medical Center of Chinese PLA General Hospital, Beijing 100091, China.
Vaccines
|August 26, 2023
概括
开发新的结核病 (TB) 疫苗至关重要,因为目前的Bacillus Calmette-Guérin (BCG) 疫苗的疗效有限. 了解宿主-病原体相互作用是推动新型结核病疫苗研究的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- 由Mycobacterium tuberculosis (MTB) 引起的结核病 (TB) 仍然是一个重大的全球卫生挑战.
- 现有的Bacillus Calmette-Guérin (BCG) 疫苗提供有限的保护,特别是在成年人中.
- 一个世纪的研究尚未产生一种普遍有效的结核病疫苗.
研究的目的:
- 审查结核病疫苗开发当前面临的挑战.
- 强调宿主-病原体相互作用机制对于新型疫苗设计的重要性.
- 总结结核结核疫苗研究的进展和未来方向.
主要方法:
- 关于结核病疫苗研究的综合文献综述.
- 在临床前和临床开发中对各种结核病疫苗候选人的评估.
- 分析开发新型结核病疫苗的障碍和机遇.
主要成果:
- 确定了结核病疫苗研究中的关键障碍.
- 评估了多种不同的疫苗平台,包括mRNA和病毒样粒子 (VLP) 疫苗.
- 强调了宿主-病原体相互作用在指导未来研究中的关键作用.
结论:
- 新型结核病疫苗的开发需要对宿主-病原体相互作用有更深入的了解.
- 像mRNA和VLP这样的新兴疫苗技术显示出有希望.
- 持续的研究和探索新的策略对于有效打击结核病至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
Pulmonary Tuberculosis IV
162
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
162
Pulmonary Tuberculosis II
262
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
262
Pulmonary Tuberculosis V
200
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
200
Pulmonary Tuberculosis I
265
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
265
Pulmonary Tuberculosis III
363
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
363


